Need Help?

Combinatorial Tumor Suppressor Gene Targeting in pancreatic duct cells, Department of Experimental Surgery, Charité Universitätsmedizin, Berlin

Generation of novel, immortalized pancreatic duct epithelial cells through combinatorial CRISPR/Cas9 gene editing main driver genes. In-depth genomic signature confirmed gene editing and revealed deterministic structural changes from early to later passages. Purpose: The purpose of the study is to generate long-read sequencing data to analyze structural variants in primary duct cell lines at two distinct evolutionary time points (passage 10 and 25).

Charité Data access agreement

This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.